Bonstein Sara
SEC insider (Form 3/4/5 filer). CIK 0001604019. Director at Latigo Biotherapeutics, Inc. (LTGO) and 3 other issuers. 52 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BRIDGEWATER, NJ.
Companies Bonstein Sara has filed insider reports for
- Latigo Biotherapeutics, Inc. (LTGO): Director
- Xilio Therapeutics, Inc. (XLO): Director
- INSMED Inc (INSM): Officer, Chief Financial Officer
- scPharmaceuticals Inc. (SCPH): Director
Bonstein Sara
CIK: 0001604019
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (52 total)
- Jun 11, 2026XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
5K shares- - Jun 3, 2026INSM
INSMED Inc
SaleDirect2.4K shares at avg. $102.27$246K - May 13, 2026INSM
INSMED Inc
SaleDirect8.3K shares at avg. $116.18$961K - Feb 3, 2026INSM
INSMED Inc
SaleDirect748 shares at avg. $156.34$117K - Jan 8, 2026INSM
INSMED Inc
SaleDirect1.4K shares at avg. $174.17$252K - Jan 7, 2026INSM
INSMED Inc
SaleDirect1.7K shares at avg. $175.07$294K - Jan 6, 2026INSM
INSMED Inc
SaleDirect1.5K shares at avg. $173.33$263K - Jan 2, 2026INSM
INSMED Inc
AwardDirect5.6K shares- - Jan 2, 2026INSM
INSMED Inc
AwardDirect6K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
DispositionDirectStock Option (Right to Buy)
30K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 5,000 | - | - | Direct |
| Jun 3, 2026 |  INSM INSMED Inc | Sale | 2,404 | $102.27 | $245,857 | Direct |
| May 13, 2026 | INSM INSMED Inc | Sale | 8,272 | $116.18 | $961,041 | Direct |
| Feb 3, 2026 | INSM INSMED Inc | Sale | 748 | $156.34 | $116,942 | Direct |
| Jan 8, 2026 | INSM INSMED Inc | Sale | 1,447 | $174.17 | $252,024 | Direct |
| Jan 7, 2026 | INSM INSMED Inc | Sale | 1,678 | $175.07 | $293,767 | Direct |
| Jan 6, 2026 | INSM INSMED Inc | Sale | 1,517 | $173.33 | $262,942 | Direct |
| Jan 2, 2026 | INSM INSMED Inc | Award | 5,645 | - | $0 | Direct |
| Jan 2, 2026 | INSM INSMED Inc | Award | 5,998 | - | $0 | Direct |
| Oct 7, 2025 |  SCPH scPharmaceuticals Inc. | Disposition Stock Option (Right to Buy) | 30,000 | - | - | Direct |
1-10 of 52 transactions